Evaluation of the efficacy of Ashwagandha in chronic knee pain among older adults with knee osteoarthritis A Protocol of a double-blind randomized controlled trial
Mundada, P. S.; Kuchewar, V.; Raut, M.; Garg, D.; Gupta, B.
Show abstract
Background: Chronic knee pain, primarily due to knee osteoarthritis, significantly impairs quality of life of the elderly by restricting mobility, reducing physical activity, and contributing to psychological distress such as depression and anxiety. The standard of care include pharmacological treatments (e.g., NSAIDs, analgesics), physical therapy, lifestyle modifications, and, in severe cases, surgical interventions, most of which often do not provide sustained relief, may carry adverse effects, and lead to poly-pharmacy, particularly in elderly patients with comorbidities. Ashwagandha is known to have Balya (strengthening) and Rasayana (adaptogenic/ rejuvenating) properties, pacifies Vata and thus may be helpful in mitigating chronic musculoskeletal pain. Objective: To evaluate the efficacy of oral Ashwagandha & Til Taila Abhyanga for six weeks on chronic knee pain, functionality, mobility, quality of life, general wellbeing, sleep quality of the older adults with knee osteoarthritis. Materials & Methods: Patients of any gender, above 60 years age and having pain in one or both knee joints since more than 3 months and average severity rated [≥]4 on the Wong-Baker Faces, due to knee osteoarthritis diagnosed as per the American College of Rheumatology Criteria are being included in the study. Medically unstable and non-ambulatory patients with severity Grade>4 of Kellgren and Lawrence scale for OA, BMI[≥]30 kg/m2, those on recent treatment with intra-articular injections or Ayurveda medications, having knee implant or fixed flexion deformity in knees, history of acute trauma, or with severe systemic/infectious ailments or other chronic conditions affecting the knee joint are excluded. Total 72 participants are enrolled and allocated randomly to either group. Participants are given either Ahwagandha Churna or Boswellia extract as oral medication for 45 days. Til Taila and standard operating procedure of Abhyanga (external oleation through massage) at the affected knee are given in both groups. The severity of pain is assessed by the numeric pain rating scale after every 15 days. Other outcomes are change in Knee Injury and Osteoarthritis Outcome Score, score of WHO Wellbeing Index -5, Global Sleep Assessment Questionnaire, Five Times Sit and Stand test and Time to Up and Go, after the intervention period. The need for conventional analgesics through the study duration is also observed and will be compared in both groups. Discussion: The outcomes of this double-blind randomized controlled trial will inform about the efficacy of Ashwagandha which is generally considered as Balya in alleviating chronic pain of knee osteoarthritis among elderly. This study can generate evidence and lead to larger effectiveness studies on role of adding Ashwagandha to the standard care for management of chronic musculoskeletal pain in older adults.
Matching journals
The top 1 journal accounts for 50% of the predicted probability mass.
Similar papers in this journal
- Effects of joint mobilization combined with acupuncture on pain, physical function, and depression in stroke patients with chronic neuropathic pain: a randomized controlled trial 96%
- Antioxidant enriched fraction from Pueraria tuberosa alleviates ovariectomized-induced osteoporosis in rats, and inhibits growth of breast and ovarian cancer cell lines in vitro 95%
- Mapping the intersection of social status and comorbidity in knee osteoarthritis: a WOMAC-based study 95%
Similar papers in this journal
- The Effects of Pericapsular nerve group (PENG) block on Postoperative Recovery in Elderly Patients with Hip fracture: a study protocol for randomized, parallel controlled, double-blind trial 95%
- International Prevalence Of Consultation With A Naturopathic Practitioner: A Systematic Review And Meta-Analysis 94%
- Exploring Risk Factors for Comorbid Depression in Osteoarthritis: A Scoping Review Protocol 94%
Similar papers in this journal
- Plant Formulation ATRICOV 452 in Improving the Level of COVID-19 Specific Inflammatory Markers in Patients 95%
- Erroneous risks in pharmaceutical versus non-pharmaceutical interventions during data extraction in evidence synthesis practice: Study protocol for a randomized controlled trial 91%
- Assessing the effectiveness of animal therapy on alleviation of anxiety in pre-school children 89%
Similar papers in this journal
- Randomized, double blind, placebo controlled, clinical trial to study co-administration of Ashwagandha on safety, immunogenicity, and protection with COVID-19 vaccine – A Study Protocol 96%
- Jinhua Qinggan Granules for Nonhospitalized COVID-19 Patients: a Double-Blind, Placebo-Controlled, Randomized Controlled Trial 94%
- Modified Preparation Method of Ideal Platelet-Rich Fibrin Matrix (PRFM) from Whole Blood 92%
Similar papers in this journal
- L-arginine and aged garlic extract for the prevention of migraine: a study protocol for a randomised, double-blind, placebo-controlled, phase-II trial (LARGE trial) 90%
- Audio-Visual Stimulation Therapy for Chronic Neuropathic Pain: A Sham-Controlled Randomized Clinical Trial 88%
- Efficacy and safety of tirofiban following intravenous thrombolysis: A systematic review and meta-analysis of randomized controlled trials 87%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.